KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Other financing activities (2016 - 2025)

Charles River Laboratories International has reported Other financing activities over the past 16 years, most recently at -$1.3 million for Q4 2025.

  • Quarterly results put Other financing activities at -$1.3 million for Q4 2025, up 70.61% from a year ago — trailing twelve months through Dec 2025 was -$14.0 million (up 55.4% YoY), and the annual figure for FY2025 was -$14.0 million, up 55.4%.
  • Other financing activities for Q4 2025 was -$1.3 million at Charles River Laboratories International, up from -$6.2 million in the prior quarter.
  • Over the last five years, Other financing activities for CRL hit a ceiling of $40.6 million in Q3 2021 and a floor of -$15.5 million in Q2 2022.
  • Median Other financing activities over the past 5 years was -$2.3 million (2021), compared with a mean of -$1.3 million.
  • Biggest five-year swings in Other financing activities: plummeted 85750.0% in 2022 and later skyrocketed 70.61% in 2025.
  • Charles River Laboratories International's Other financing activities stood at $2000.0 in 2021, then plummeted by 85750.0% to -$1.7 million in 2022, then crashed by 141.97% to -$4.1 million in 2023, then decreased by 9.58% to -$4.5 million in 2024, then skyrocketed by 70.61% to -$1.3 million in 2025.
  • The last three reported values for Other financing activities were -$1.3 million (Q4 2025), -$6.2 million (Q3 2025), and -$6.5 million (Q2 2025) per Business Quant data.